微信小陈
微信小章
产品简介
购买须知
| 产品名称： | Mannheimia haemolytica (Newsom and Cross) Angen et al. |
|---|---|
| 商品货号： | TS138888 |
| Deposited As： | Pasteurella haemolytica Newsom and Cross |
| Strain Designations： | NADC-D60aroA- |
| Application： | Used to produce live, attenuated veterinary vaccines against Pasteurella haemolytica |
| Isolation： | Lung from cow with pneumonic pasteurellosis |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Storage Conditions： | Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Type Strain： | no |
| Medium： | ATCC® Medium 44: Brain Heart Infusion Agar/Broth ATCC® Medium 260: Trypticase soy agar/broth with defibrinated sheep blood |
| Growth Conditions： | Temperature: 37°C
Atmosphere: Aerobic |
| Name of Depositor： | National Animal Disease Center, ARS, USDA |
| U.S. Patent Number： | |
| Special Collection： | NCRR Contract |
| References： | Briggs RE, Tatum FM. Construction of Pasteurella haemolytica vaccines. US Patent 5,733,780 dated Mar 31 1998 |